跳至主要内容
临床试验/CTRI/2023/05/052924
CTRI/2023/05/052924尚未招募3 期

RANDOMIZED COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFECT OF ERANDAMULADI NIRUHA BASTI AND MADHUTAILIK BASTI IN THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME IN THE REPRODUCTIVE AGE WOMEN.

SANDHYA MADHUKAR YENNAWAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed cases ofPCOS (by Rotterdam criteria)- Any 2/3.
  • a. Hyperandrogenism (Clinical or biochemical).
  • b. Oligomenorrhea (menstrual cycle >35 days)/ Secondary amenorrhea
  • (menstrual cycle >90 days but < 180 days).
  • c. USG findings- PCO features on USG i.e. peripherally Arranged Antral Follicle Count >12 with thickened stroma in ovaries and/or Ovarian volume >10 cm 3 in Unilateral or Bilateral ovaries.
  • Patient fit for basti.

排除标准

  • A. Patient of age group <18 and >35years.
  • B. Patients showing sign & symptoms other than PCOS.
  • C. Patient having any other disease causing oligomenorrhea and anovulation excluding PCOS on above criteria i.e.Hypogonadotrophic hypogonadism, premature ovarian failure.
  • D. Known cases of
  • a) Congenital adrenal hyperplasia
  • b) Severe insulin resistance (insulin dependent diabetes mellitus)
  • c) Androgen secreting ovarian and adrenal tumors d) Thyroid abnormalities
  • e) Cushing syndrome
  • f) Cardiac disease
  • g) Hyperprolactinemia.
  • E. Patient with any organic lesions of reproductive tract like TB, CA,
  • Congenital anomalies, any other pelvic pathologies.
  • F. A current or previous (within 3 months) use of OC Pills, glucocorticoids, antiandrogens, antidiabetics, anti-obesity drugs or any
  • hormonal therapy.
  • G. Pregnant patients.

研究者

发起方
SANDHYA MADHUKAR YENNAWAR

相似试验

Erandamuladi Niruha Basti and Madhutailik Basti in... | 临床试验